Bryan Kipp – From Columbia Athlete to Revvity Executive and Former Partner of Tennis Star Danielle Collins
Who is Bryan Kipp?
Bryan Kipp is an accomplished American business executive best known for his senior leadership role at Revvity, a global life-sciences and diagnostics company headquartered in Waltham, Massachusetts. With a strong academic foundation in industrial engineering and an impressive corporate trajectory across the biotechnology and financial sectors, Kipp has become a respected name in the intersection of science, business strategy, and innovation.
Born in December 1988 in Pittsburgh, Pennsylvania, Bryan Kipp is currently 36 years old as of 2025. He is a graduate of Columbia University’s Fu Foundation School of Engineering and Applied Science, where he earned a Bachelor of Science in Industrial Engineering and Operations Research in 2011. During his years at Columbia, Kipp wasn’t just known for his academic excellence—he was also a formidable athlete, playing American football for the Columbia Lions as an offensive guard and defensive lineman. His leadership and athletic discipline later translated seamlessly into his corporate career.
Bryan Kipp’s Early Life and Education
Columbia University and Athletic Achievements
At Columbia, Bryan Kipp demonstrated the rare ability to balance a demanding academic workload with competitive athletics. He represented the university in the Ivy League Football Team, where he earned recognition for his dedication, strength, and teamwork. His role on the field reflected qualities that would define his career: resilience, strategic thinking, and the ability to perform under pressure.
His time at the Fu Foundation School of Engineering and Applied Science helped him develop a strong analytical mindset and technical proficiency. The programme’s focus on systems optimisation and quantitative analysis equipped Kipp with the tools necessary for data-driven decision-making—skills that later became essential in his corporate strategy roles.
Bryan Kipp’s Career Journey
Beginnings in Finance and Investment Research
After graduating, Bryan Kipp began his professional career in the financial industry, taking on analytical roles that combined his technical and quantitative background with business insights. Between 2012 and 2018, he worked for major financial institutions including CLSA, Janney Montgomery Scott LLC, and Citi, where he specialised in life-science tools and diagnostics industry research. His work in equity research and investment analysis focused on evaluating biotechnology and diagnostics firms—an early indication of his growing interest in the life-sciences sector.
Kipp’s analytical expertise was further recognised when he joined Balyasny Asset Management L.P., a global investment management firm based in New York. His experience there deepened his understanding of the commercial dynamics of the life-sciences industry and provided him with the financial acumen necessary for leadership in a corporate setting.
Transition to PerkinElmer and the Road to Revvity
In 2019, Bryan Kipp transitioned from finance into the biotechnology and diagnostics sector, joining PerkinElmer Inc., a global scientific instruments and diagnostics company. His early role as Vice President of Investor Relations placed him at the intersection of corporate communication, finance, and scientific innovation. He was responsible for engaging with investors, communicating strategic objectives, and supporting the company’s long-term growth narrative.
In 2021, his leadership potential earned him a promotion to Vice President and General Manager of Life Science Strategy & Integration, based in London, UK. This position required overseeing major strategic initiatives, mergers, and the integration of global life-science operations—a pivotal step that strengthened PerkinElmer’s market presence.
Revvity: Senior Vice President of Technology & Licensing
When PerkinElmer rebranded its life-science and diagnostics business as Revvity in 2023, Bryan Kipp was one of the key executives retained to lead the company’s transformation. His title evolved from VP/GM of Life Science Strategy & Integration to Senior Vice President, Technology & Licensing in May 2024.
As SVP Technology & Licensing, Kipp oversees Revvity’s global innovation partnerships, intellectual-property licensing, and strategic collaborations across genomics, diagnostics, and healthcare technologies. His leadership role includes fostering collaboration between research institutions, biotech start-ups, and healthcare policymakers.
Kipp’s influence within Revvity has been recognised publicly—he was mentioned in Gisela Abbam’s LinkedIn post highlighting Revvity’s delegation to 10 Downing Street to discuss healthcare access, genomics, and diagnostics with UK policymakers. This underscores his prominence in shaping strategic dialogue around healthcare innovation in both the United States and the UK.
Professional Ethos and Leadership Style
Bryan Kipp’s leadership philosophy combines the analytical precision of an engineer with the vision of a strategist. His background in investor relations has made him adept at bridging communication between scientific innovation and market expectations. Colleagues describe his approach as disciplined, methodical, and forward-looking—qualities likely influenced by his years of competitive sport.
At Revvity, he is known for promoting interdisciplinary collaboration, ensuring that technology development aligns with real-world healthcare outcomes. Under his guidance, Revvity continues to expand its global footprint, focusing on sustainable innovation and equitable healthcare access.
Bryan Kipp and Danielle Collins
The Relationship Story
Bryan Kipp first came into wider public recognition not just for his professional achievements but through his relationship with Danielle Collins, the celebrated American tennis player. The pair reportedly met in London during Kipp’s posting there and began dating in 2024. Their relationship gained attention due to the couple’s high-profile careers—Collins being a world-class athlete and Kipp a biotechnology executive.
They were frequently seen attending major tennis tournaments together, and Collins often spoke of his support during her health challenges. However, in October 2025, Collins confirmed that she and Bryan Kipp had ended their relationship after more than a year together.
Danielle Collins’ Health Journey
Danielle Collins has been candid about her struggles with rheumatoid arthritis and endometriosis, both chronic inflammatory conditions that have affected her athletic career. Her decision to retire from professional tennis in 2024 was deeply connected to managing her long-term health and planning for her personal life.
Following the breakup, Collins attracted media attention when her dating-profile comments went viral—stating that she was seeking a serious partner and was not interested in “short kings.” The comment became a pop-culture talking point but also highlighted her forthright personality.
Public Reaction to Bryan Kipp and Danielle Collins’ Break-Up
The end of Danielle Collins and Bryan Kipp’s relationship was widely reported in outlets such as People, Daily Mail, and New York Post. While the media focused on her outspoken dating remarks, sources close to the pair noted that the breakup appeared amicable. Both have continued to focus on their respective professional pursuits—Collins on post-tennis advocacy and wellness, and Bryan Kipp on executive leadership within the biotech sector.
Bryan Kipp Age, Background, and Personal Life
As of 2025, Bryan Kipp’s age is 36, turning 37 in December. He was born and raised in the Boston area, attending Xaverian Brothers High School, where he excelled in multiple sports, including football, track, and wrestling. His background as a student-athlete instilled the work ethic and competitive drive that define his professional persona.
Outside of work, Kipp is known for maintaining a low profile. His social-media activity is limited; his X (Twitter) account, @KippBryan2, shows minimal posts, mostly related to PerkinElmer investor updates. He appears to value privacy, preferring to let his professional accomplishments speak for themselves.
Bryan Kipp Net Worth and Financial Standing
While Bryan Kipp’s net worth is not publicly disclosed, reasonable estimates suggest that his earnings as a senior executive at Revvity place him within the upper echelons of corporate biotechnology leadership. Comparable roles in the US life-sciences industry often command annual compensations exceeding $400,000, excluding bonuses, stock options, and long-term incentives.
Given his career trajectory—from major investment firms to leading positions in global biotech corporations—it is plausible that Bryan Kipp’s net worth runs into several million US dollars. However, without formal disclosures, any figure should be treated as an informed estimate rather than a confirmed amount.
Legacy and Future Prospects
At just 36, Bryan Kipp has already built a career spanning finance, biotechnology, and global leadership. His transition from Wall Street analyst to senior executive in one of the world’s top life-science firms illustrates a rare blend of technical knowledge and strategic insight.
Looking ahead, Kipp is expected to continue driving Revvity’s innovation pipeline, focusing on technology partnerships, intellectual-property licensing, and strategic alliances that enhance healthcare accessibility. His influence extends beyond corporate walls, representing a new generation of science-driven executives committed to societal impact.
Final Thoughts
Bryan Kipp stands out as a professional who seamlessly bridges the gap between analytical finance, advanced science, and public healthcare policy. His story—from the football fields of Columbia University to the boardrooms of Revvity—demonstrates how discipline, intellect, and perseverance can forge a path to global leadership.
Although his relationship with Danielle Collins brought him brief celebrity attention, his enduring legacy lies in his contribution to life-science innovation and executive excellence. At 36, Bryan Kipp’s journey is only beginning, and his blend of technical expertise, strategic foresight, and quiet determination ensures his name will remain significant in the biotechnology industry for years to come.
Frequently Asked Questions (FAQs)
1. Who is Bryan Kipp?
Bryan Kipp is an American business executive and former college football player who currently serves as Senior Vice President of Technology & Licensing at Revvity, a global life-sciences and diagnostics company. He is a graduate of Columbia University with a degree in Industrial Engineering and Operations Research.
2. How old is Bryan Kipp?
Bryan Kipp was born in December 1988, making him 36 years old as of 2025. He will turn 37 in December 2025.
3. What is Bryan Kipp’s connection to Danielle Collins?
Bryan Kipp was previously in a relationship with Danielle Collins, the American tennis star. The couple dated for over a year before confirming their split in October 2025. Their relationship gained attention due to their respective high-profile careers.
4. What is Bryan Kipp’s net worth?
While no verified public figure exists for Bryan Kipp’s exact net worth, his senior executive role at Revvity likely places him among high-earning corporate leaders in the life-sciences industry. Industry estimates suggest compensation packages that could total several million US dollars including salary, bonuses, and stock awards.
5. Where did Bryan Kipp study?
Bryan Kipp studied at Columbia University’s Fu Foundation School of Engineering and Applied Science, earning a Bachelor of Science in Industrial Engineering and Operations Research. He was also a member of the Columbia Lions football team during his undergraduate years.
